PRKDC: new biomarker and drug target for checkpoint blockade immunotherapy.
Tan KT, Yeh CN, Chang YC, Cheng JH, Fang WL, Yeh YC, Wang YC, Hsu DS, Wu CE, Lai JI, Chang PM, Chen MH, Lu ML, Chen SJ, Chao Y, Hsiao M, Chen MH.
Tan KT, et al. Among authors: hsu ds.
J Immunother Cancer. 2020 Mar;8(1):e000485. doi: 10.1136/jitc-2019-000485.
J Immunother Cancer. 2020.
PMID: 32238472
Free PMC article.